LCI Industries
LCII
80.12
-2.07
-2.52%
LCI Industries
US · LCII
#2784 by market cap
Listed 2017
80.12
-2.07
-2.52%
Live - 5344 symbols - heartbeat 512s ago
· 2026-10-08 02:44
After-hours
80.12
0.00%
Overnight
80.00
-0.15%
- Market cap
- 1.95B
- P/E (TTM)i
- 9.28
- P/Bi
- 1.36
- EPSi
- 7.57
- Div yieldi
- 5.74%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on LCII?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.13, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.18% YoY
Margins
- Gross margin
- 23.78%
- Operating margin
- 6.79%
- Net margin
- 4.57%
Key ratios & quality
- Enterprise valuei
- 2.71B
- Altman Z-Scorei
- 3.13
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.48B | 2.37B | 2.80B | 4.47B | 5.21B | 3.78B | 3.74B | 4.12B |
| Gross profit | 520.34M | 539.20M | 706.09M | 1.04B | 1.27B | 776.19M | 879.72M | 980.30M |
| Selling & admin expenses | 321.56M | 338.99M | 483.16M | 644.63M | 720.26M | 453.33M | 465.00M | 495.31M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 198.79M | 200.21M | 222.93M | 398.41M | 553.03M | 123.43M | 218.24M | 279.92M |
| Pretax profit | 192.35M | 191.41M | 209.48M | 382.04M | 525.46M | 83.00M | 189.34M | 255.07M |
| Tax | 43.80M | 44.91M | 51.04M | 94.31M | 130.48M | 18.81M | 46.47M | 66.82M |
| Net profit | 148.55M | 146.51M | 158.44M | 287.74M | 394.97M | 64.20M | 142.87M | 188.25M |
| Basic EPS | 6 | 6 | 6 | 11 | 16 | 3 | 6 | 8 |
| Diluted EPS | 5.83 | 5.84 | 6.27 | 11.32 | 15.48 | 2.52 | 5.60 | 7.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.11B | 1.04B | 932.70M | 1.09B | 968.68M |
| Gross profit | 251.75M | 270.02M | 252.61M | 205.91M | 273.67M | 301.14M |
| Selling & admin expenses | 120.58M | 127.98M | 177.17M | -34.51M | 122.62M | 143.84M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 81.32M | 87.80M | 75.44M | 35.36M | 95.16M | 95.96M |
| Pretax profit | 67.27M | 78.12M | 84.03M | 25.66M | 85.25M | 90.20M |
| Tax | 17.84M | 20.48M | 21.53M | 6.97M | 22.30M | 23.05M |
| Net profit | 49.44M | 57.64M | 62.49M | 18.68M | 62.95M | 67.14M |
| Basic EPS | 2 | 2 | 3 | 1 | 3 | 3 |
| Diluted EPS | 1.94 | 2.29 | 2.55 | 0.77 | 2.53 | 2.75 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 526.65M | 670.79M | 869.80M | 1.57B | 1.39B | 1.12B | 1.16B | 1.35B |
| Cash & ST investments | 14.93M | 35.36M | 51.82M | 62.90M | 47.50M | 66.16M | 165.76M | 222.62M |
| Inventory | 340.62M | 393.61M | 493.90M | 1.10B | 1.03B | 768.41M | 736.60M | 809.09M |
| Total assets | 1.24B | 1.86B | 2.30B | 3.29B | 3.25B | 2.96B | 2.89B | 3.18B |
| Total current liabilities | 177.58M | 271.26M | 416.39M | 627.22M | 421.30M | 394.99M | 412.05M | 473.37M |
| Short-term debt | 596.00K | 39.58M | 43.26M | 101.60M | 58.53M | 36.86M | 39.09M | 47.86M |
| Long-term debt | 293.53M | 612.91M | 720.42M | 1.23B | 1.10B | 846.83M | 756.83M | 941.50M |
| Total liabilities | 537,638,000.00 | 1,061,923,000.00 | 1,389,705,000.00 | 2,195,219,000.00 | 1,865,904,000.00 | 1,604,283,000.00 | 1,507,853,000.00 | 1,815,154,000.00 |
| Total equity | 706.26M | 800.67M | 908.33M | 1.09B | 1.38B | 1.36B | 1.39B | 1.36B |
| Retained earnings | 563.50M | 644.95M | 731.71M | 930.80M | 1.22B | 1.18B | 1.21B | 1.28B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.37B | 1.36B | 1.37B | 1.35B | 1.42B | 1.48B |
| Cash & ST investments | 231.24M | 191.93M | 199.72M | 222.62M | 142.24M | 216.51M |
| Inventory | 717.44M | 710.29M | 741.28M | 809.09M | 834.45M | 768.98M |
| Total assets | 3.10B | 3.17B | 3.17B | 3.18B | 3.22B | 3.27B |
| Total current liabilities | 461.27M | 484.30M | 492.18M | 473.37M | 487.98M | 597.25M |
| Short-term debt | 41.19M | 43.13M | 43.94M | 47.86M | 48.65M | 48.89M |
| Long-term debt | 934.63M | 944.31M | 944.17M | 941.50M | 941.34M | 848.93M |
| Total liabilities | 1,733,285,000.00 | 1,789,038,000.00 | 1,806,911,000.00 | 1,815,154,000.00 | 1,829,581,000.00 | 1,836,150,000.00 |
| Total equity | 1.37B | 1.39B | 1.36B | 1.36B | 1.39B | 1.43B |
| Retained earnings | 1.23B | 1.26B | 1.29B | 1.28B | 1.31B | 1.35B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 156.61M | 269.53M | 231.40M | -111.57M | 602.51M | 527.23M | 370.28M | 330.98M |
| Depreciation & amortization | 67.53M | 75.36M | 97.98M | 112.32M | 129.21M | 131.77M | 125.69M | 121.23M |
| Free cash flow | 36.78M | 211.32M | 174.05M | -210.11M | 471.87M | 465.02M | 327.95M | 278.33M |
| Dividends paid | -59.27M | -63.81M | -70.40M | -87.17M | -102.73M | -106.34M | -109.47M | -114.04M |
| Stock buybacks / issuance | -28.70M | -- | 0 | 0 | -24.05M | 0 | 0 | -128.57M |
| Ending cash balance | 14.93M | 35.36M | 51.82M | 62.90M | 47.50M | 66.16M | 165.76M | 222.62M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 42.72M | 112.22M | 97.17M | 78.87M | -33.46M | 203.68M |
| Depreciation & amortization | 29.54M | 30.32M | 30.49M | 30.88M | 29.80M | 30.86M |
| Free cash flow | 33.68M | 99.48M | 80.87M | 64.30M | -43.13M | 184.91M |
| Dividends paid | -29.35M | -29.04M | -27.83M | -27.83M | -27.93M | -27.95M |
| Stock buybacks / issuance | -28.26M | -38.08M | -62.23M | 0 | 0 | 0 |
| Ending cash balance | 231.24M | 191.93M | 199.72M | 222.62M | 142.24M | 216.51M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 21.86 | 19.44 | 18.54 | 28.76 | 31.93 | 4.69 | 10.42 | 13.70 |
| ROA %i | 13.57 | 9.43 | 7.62 | 10.30 | 12.09 | 2.07 | 4.88 | 6.20 |
| ROIC %i | 18.04 | 11.91 | 10.26 | 13.88 | 15.61 | 3.66 | 6.80 | 8.62 |
| 5-year avg ROE %i | 21.12 | 21.49 | 21.63 | 22.14 | 24.11 | 20.67 | 18.87 | 17.90 |
| EBIT margin %i | 8.03 | 8.44 | 7.97 | 8.91 | 10.62 | 3.26 | 5.83 | 7.05 |
| FCF / sales %i | 1.49 | 8.91 | 6.22 | -- | 9.06 | 12.29 | 8.77 | 6.75 |
| Current ratioi | 2.97 | 2.47 | 2.09 | 2.50 | 3.30 | 2.83 | 2.82 | 2.85 |
| Quick ratioi | 0.77 | 0.87 | 0.77 | 0.61 | 0.62 | 0.71 | 0.89 | 0.98 |
| Debt / assetsi | 23.65 | 39.32 | 36.83 | 44.92 | 42.41 | 37.39 | 34.40 | 38.90 |
| LT debt / equityi | 41.56 | 86.52 | 88.42 | 125.85 | 95.46 | 78.93 | 68.99 | 87.27 |
| Interest coveragei | 30.89 | 22.76 | 16.57 | 24.34 | 20.06 | 3.05 | 7.55 | 8.14 |
| Revenue CAGR (3Y) %i | 20.84 | 12.20 | 9.19 | 21.79 | 29.98 | 10.62 | -5.78 | -7.49 |
| Net income CAGR (3Y) %i | 25.95 | 4.15 | 6.04 | 24.65 | 39.18 | -26.00 | -20.81 | -21.89 |
| FCF CAGR (3Y) %i | -17.72 | 10.41 | 38.52 | -- | 30.71 | 38.76 | -- | -16.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.44 | 10.95 | 12.89 | 13.70 | 14.65 | 15.00 |
| ROA %i | 5.12 | 4.92 | 5.78 | 6.20 | 6.39 | 6.56 |
| ROIC %i | 6.98 | 6.82 | 8.01 | 8.62 | 8.95 | 9.22 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.12 | 5.97 | 6.80 | 7.05 | 7.50 | 7.98 |
| FCF / sales %i | 9.90 | 7.68 | 7.76 | 6.75 | 4.84 | 7.12 |
| Current ratioi | 2.96 | 2.80 | 2.78 | 2.85 | 2.91 | 2.49 |
| Quick ratioi | 1.28 | 1.19 | 1.15 | 0.98 | 1.06 | 1.00 |
| Debt / assetsi | 37.92 | 37.90 | 37.86 | 38.90 | 38.40 | 35.07 |
| LT debt / equityi | 83.00 | 83.75 | 84.87 | 87.27 | 85.55 | 76.64 |
| Interest coveragei | 9.15 | 8.47 | 8.73 | 8.14 | 7.89 | 8.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Original equipment manufacturers (OEMs) is the largest reported line at 69.66% of revenue, across 2 reported segments.
- Aftermarket follows at 30.34%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Original equipment manufacturers (OEMs)69.66%
Aftermarket30.34%
Quote time 2026-10-08 02:44:22 · For reference only, not investment advice and not tailored to your situation.